Table 2.
Sample 1 % reporting among sample of placebo-controlled trials published in top journals (n=94) |
Sample 2 % reporting among sample of placebo-controlled trials (n=100) |
Sample 3 % reporting among placebo-controlled trials that reported using TIDieR (n=6) |
|
---|---|---|---|
Mentioned using TIDieR | 0 | 0 | 100 |
TIDieR item | |||
Brief name | 100 | 98 | 100 |
Why | 8.5 | 7 | 16.7 |
What (materials) | 68.1 | 60 | 33.3 |
What (procedures) | 92.6 | 65 | 100 |
Who provided | 45.7 | 59 | 83.3 |
How | 68.1 | 82 | 83.3 |
Where | 68.1 | 63 | 100 |
When and how much | 97.9 | 89 | 100 |
Tailoring | 59.6 | 15 | 50 |
Modifications | 25.5 | 4 | 33.3 |
How well (planned adherence/fidelity assessment) | 55.3 | 20 | 33.3 |
How well (actual adherence/fidelity) | 54.3 | 12 | 33.3 |
Addressed all TIDieR items | 0 | 0 | 0 |
Mean number of items addressed | 7.5 (SD 1.8) | 5.7 (SD 1.7) | 7.7 (SD 2.5) |
SD= standard deviation